These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3349228)

  • 1. Cardiovascular effects of apamin and BRL 34915 in rats and rabbits.
    Cook NS; Hof RP
    Br J Pharmacol; 1988 Jan; 93(1):121-31. PubMed ID: 3349228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
    Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci.
    Weir SW; Weston AH
    Br J Pharmacol; 1986 May; 88(1):113-20. PubMed ID: 2423171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers.
    Hof RP; Quast U; Cook NS; Blarer S
    Circ Res; 1988 Apr; 62(4):679-86. PubMed ID: 2450694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats.
    Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Nov; 104(3):731-7. PubMed ID: 1797333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil.
    Coldwell MC; Howlett DR
    Biochem Pharmacol; 1987 Nov; 36(21):3663-9. PubMed ID: 2445348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast with nifedipine.
    Falotico R; Keiser J; Haertlein B; Cheung WM; Tobia A
    Proc Soc Exp Biol Med; 1989 Feb; 190(2):179-85. PubMed ID: 2915996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
    Buckingham RE
    Br J Pharmacol; 1988 Mar; 93(3):541-52. PubMed ID: 3370388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
    Winquist RJ; Heaney LA; Wallace AA; Baskin EP; Stein RB; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1989 Jan; 248(1):149-56. PubMed ID: 2464055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
    Cavero I; Mondot S; Mestre M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressor effects of the alpha 2-adrenoceptor agonist B-HT 933 in anaesthetized and haemorrhagic rats: comparison with the haemodynamic effects of amidephrine.
    MacLean MR; Thomson M; Hiley CR
    Br J Pharmacol; 1989 Jun; 97(2):419-32. PubMed ID: 2569342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models.
    Buckingham RE; Clapham JC; Hamilton TC; Longman SD; Norton J; Poyser RH
    J Cardiovasc Pharmacol; 1986; 8(4):798-804. PubMed ID: 2427821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent and BRL 34915-induced vasodilatation in rat isolated perfused mesenteric arteries: role of G-proteins, K+ and calcium channels.
    Adeagbo AS; Malik KU
    Br J Pharmacol; 1990 Jul; 100(3):427-34. PubMed ID: 2167732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
    Hayashi K; Matsumura Y; Yoshida Y; Ohyama T; Hisaki K; Suzuki Y; Morimoto S
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1240-6. PubMed ID: 2108239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lack of involvement of cyclic nucleotides in the smooth muscle relaxant action of BRL 34915.
    Gillespie JS; Sheng H
    Br J Pharmacol; 1988 Aug; 94(4):1189-97. PubMed ID: 2850057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cromakalim, a potassium channel opener, on regional blood flow in conscious spontaneously hypertensive rats.
    Shoji T; Aki Y; Fukui K; Tamaki T; Iwao H; Abe Y
    Eur J Pharmacol; 1990 Sep; 186(1):119-23. PubMed ID: 2282933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
    Post JM; Smith JM; Jones AW
    J Pharmacol Exp Ther; 1989 Aug; 250(2):591-7. PubMed ID: 2760842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats.
    Struijker Boudier HA; Messing MW; van Essen H
    Eur J Pharmacol; 1992 Jul; 218(1):191-3. PubMed ID: 1397031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.